rxstatShortages › Bimatoprost

Bimatoprost shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Bimatoprost products are in shortage in Canada (1 of 2 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Products affected
1 of 2
In shortage since
Apr 1, 2011
Reports on file
8
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
LUMIGAN
0.03% · SOLUTION · ALLERGAN INC
DIN 02245860 · since Apr 1, 2011, no end estimate · Other (Please describe in comments)
Resolved
VISTITAN
0.03% · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02429063 · ended May 19, 2026 · Disruption of the manufacture of the drug.
Resolved
VISTITAN
0.03% · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02429063 · ended Oct 15, 2024 · Disruption of the manufacture of the drug.
Resolved
VISTITAN
0.03% · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02429063 · ended Jun 25, 2024 · Shortage of an active ingredient.
Resolved
VISTITAN
0.03% · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02429063 · ended Apr 21, 2023 · Disruption of the manufacture of the drug.
Resolved
VISTITAN
0.03% · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02429063 · ended Jul 6, 2022 · Delay in shipping of the drug.
Resolved
VISTITAN
0.03% · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02429063 · ended Mar 24, 2022 · Delay in shipping of the drug.
Resolved
VISTITAN
0.03% · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02429063 · ended Oct 4, 2021 · Disruption of the manufacture of the drug.

What's happening

Bimatoprost is currently affected by an active shortage report filed with Health Canada by ALLERGAN INC.

The reported cause is: other (please describe in comments). Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Bimatoprost is classified under “ANTIGLAUCOMA PREPARATIONS AND MIOTICS” (ATC S01EE).

Recent changes

Common questions

When will Bimatoprost be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Bimatoprost in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antiglaucoma preparations and miotics)

All antiglaucoma preparations and miotics shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.